Brainstorm Cell Therapeutics Inc.Brainstorm Cell Therapeutics Inc.Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

No trades
See on Supercharts

BCLI fundamentals

Brainstorm Cell Therapeutics Inc. earnings per share and revenue

BCLI earnings per share for the last quarter are -0.51 USD whereas the estimation was -0.57 USD which accounts for 11.30% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.36 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of BCLI earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise